Related Experiment Videos
T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A
C H Pontzer1, M J Irwin, N R Gascoigne
1Department of Microbiology and Cell Science, University of Florida, Gainesville 32611.
Summary
Researchers found that a specific peptide from the T-cell receptor beta chain variable region 3 (Vβ3) blocks staphylococcal enterotoxin A (SEA) from activating T cells. This discovery highlights a key interaction site for superantigen binding.
Area of Science:
- Immunology
- Molecular Biology
- Microbial Pathogenesis
Background:
- Staphylococcal enterotoxin A (SEA) is a microbial superantigen known to activate T cells expressing specific Vβ elements, including Vβ3.
- Understanding the molecular interactions between superantigens and T-cell receptors (TCRs) is crucial for deciphering immune responses.
Purpose of the Study:
- To investigate the interaction between SEA and peptides derived from the Vβ3 chain of the TCR.
- To identify specific regions of Vβ3 involved in SEA binding and subsequent T-cell activation.
Main Methods:
- Synthesis of five overlapping peptides representing different regions of the Vβ3 chain.
- Assays to assess the binding of soluble Vβ3-bearing beta chains to SEA-MHC class II complexes.
- Inhibition assays using synthetic peptides to measure SEA-induced interferon-gamma production and T-cell proliferation.
- Flow cytometry analysis using anti-Vβ3 monoclonal antibodies to quantify T-cell reactivity.
Main Results:
- A synthetic peptide corresponding to amino acids 57-77 of Vβ3 (Vβ3-(57-77)) was found to block the interaction between SEA and the Vβ3-bearing TCR.
- The Vβ3-(57-77) peptide inhibited SEA-induced interferon-gamma production and proliferation of B10.BR spleen cells.
- This peptide specifically inhibited SEA-induced T-cell activity, as demonstrated by a reduction in Vβ3-reactive T cells.
Conclusions:
- The Vβ3 region, specifically amino acids 57-77, is critical for the binding of SEA to the TCR.
- This region likely possesses the necessary sequence and conformation for SEA binding, thereby blocking TCR-mediated T-cell activation.
- These findings provide insights into the molecular mechanisms of superantigen-TCR interactions and potential targets for therapeutic intervention.